2001: The Start
• January: company incorporation as Byk Gulden Pty Ltd
• September: First office opens at 71 Epping Road, North Ryde
• Clinical research activities commence as a bridgehead to commercial market entry
2002: Year of Pioneering
• Business Development commences and R&D activities intensify
• Local management and support of Somac license partner
• Name change to ALTANA Pharma Pty Ltd
• Pioneering business culture introduced
2003: Year of Commitment
• Commercial activities commence with first Somac co-promotion sales team
• Increased Business Development activities
• Organisational growth to 60 employees
2004: Year of Breakthrough
• First country to achieve Alvesco registration.
• Enhanced company profile in the Australian market
• Full potential of Somac co-promotion partnership realised
• Consolidation of Sales and Marketing organisation
2005: Year of Change
• Company expansion and relocation to new offices at 2 Lyonpark Road, North Ryde.
• Alvesco launched
• Focus on developing valued customer offerings
• Organisational growth to 100 employees
2006: Year of Strength
• Strengthening of organisational functions through system & process improvement
• Increased competitiveness through the development of a best in class sales organisation
• Preparation for Somac governance
• Organisational growth to 120 staff
2007: Year of Integration
• Nycomed acquires ALTANA Pharma shares followed by local integration process
• Renewed Business Development focus
• Full Somac governance ending successful co-promotion
• Market sales exceed $100 million
2008: Year of Future
• Foundation for future through the introduction of the Nycomed strategic growth program
• Intensive Business Development activities
• Nycomed corporate values introduced
• Consumer Healthcare Division launched
• Increased external communication with new stakeholder groups
• Organisational growth to 140 staff